DataMeds AI's Corexa Health Signs Supply Agreement for Six Peptides

• DataMeds AI's subsidiary Corexa Health signed an agreement for commercial supply of bulk drug substances for six peptides.
• Corexa Pharmacy plans to begin dispensing compounded prescriptions for the peptides in November 2026 under HHS' updated enforcement discretion policy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.